Flare Capital Partners
No summary available yet.
Flare's secret sauce isn't just their $1B AUM or 77 portfolio companies - it's their co-creation model where they actually incubate businesses directly with health-system and payer partners, using those enterprises' data, workflows, and distribution as the starting point. Their strategic LP network has contributed nearly $1 billion in revenue to portfolio companies - that's not marketing fluff, that's real distribution power. Partners like Michael Greeley understand that healthcare companies are "asymptotic" - the first couple years are heads down trying to figure out product-market fit, then they get traction, and they're empathetic to that journey. The downside? They're obsessed with founder-market fit and industry experience - if you're a first-time founder without deep healthcare chops, you're probably not their cup of tea.
- —Best for: Healthcare founders with deep industry experience and existing customer relationships
- —Watch out for: Heavy emphasis on co-creation model may slow traditional VC speed
- —Known for: $1B+ revenue generated for portfolio companies through strategic LP network
Flare Capital's investment philosophy centers on backing technical founders with deep healthcare industry experience who understand "voice of the customer" and can build companies with profound impact on quality, access, and cost of care. Their thesis emphasizes founder-market fit above all else—they invest in people with significant industry experience and genuine understanding of healthcare pain points. They seek companies that can demonstrate early market validation through initial customer traction and product revenues.
Check sizes range from $2 million to $15 million across Seed to Series B stages, though primary focus is on Seed and Series A rounds. Exclusively focused on healthcare technology including enterprise software (provider and payer solutions), healthcare data & analytics, clinical AI, telemedicine/digital health, healthcare services technology, value-based care, patient engagement, and biotech.
Prior to co-founding Flare in 2013, Bill was with North Bridge Venture Partners since inception in 1994. During his nearly 30-year tenure investing in healthcare technology companies, he has served on boards of numerous industry-leading companies. Holds a BS from Boston College and an MPH in Epidemiology from Harvard.
Co-founder of Flare Capital Partners. Previously was the founding General Partner of Flybridge Capital Partners, and earlier was with Polaris Partners, as well as held positions at Wasserstein Perella & Co. and Morgan Stanley. Additionally served on the board of International Data Group, the founding partner of IDG Capital, a leading venture capital firm in China.
Has a background in healthcare policy, operating, innovation and investing. At Flare Capital he supports or has co-led investments into Aetion, HealthVerity and Suki AI. Prior to joining Flare Capital, was an investor at NewYork-Presbyterian Hospital (NYP) Ventures, where he focused on applications of artificial intelligence to healthcare operations.
Have a specific question about Flare Capital Partners?
Ask Bernie →